Catheter Precision Q4 EPS $(2.88) Up From $(21.66) YoY, Sales $238.000K Up From $149.000K YoY

Catheter Precision (AMEX: VTAK) reported a Q4 loss of $(2.88) per share, an improvement from $(21.66) per share year-over-year, reflecting an 86.7% reduction in losses. The company's sales reached $238,000, marking a 59.73% increase from $149,000 in the same quarter last year.